Cargando…

Long-term Use of Clozapine is Protective for Bone Density in Patients with Schizophrenia

Low bone mineral density (BMD) prevails among patients with schizophrenia. Antipsychotics use plays an important role in BMD. Previous cross-section study suggests that clozapine treatment may benefit BMD of women with schizophrenia. However, the effect of long-term clozapine therapy on BMD remains...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lin, Chieh-Hsin, Lin, Chun-Yuan, Wang, Hong-Song, Lane, Hsien-Yuan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2019
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6405997/ https://www.ncbi.nlm.nih.gov/pubmed/30846868 http://dx.doi.org/10.1038/s41598-019-40691-7

Ejemplares similares

Effects of Antipsychotics on Bone Mineral Density in Patients with Schizophrenia: Gender Differences
por: Chen, Chien-Yu, et al.
Publicado: (2016)

D2 dopamine receptor gene (DRD2) Taq1A (rs1800497) affects bone density
por: Chiang, Ting-I., et al.
Publicado: (2020)

Early Identification and Intervention of Schizophrenia: Insight From Hypotheses of Glutamate Dysfunction and Oxidative Stress
por: Lin, Chieh-Hsin, et al.
Publicado: (2019)

Prediction of functional outcomes of schizophrenia with genetic biomarkers using a bagging ensemble machine learning method with feature selection
por: Lin, Eugene, et al.
Publicado: (2021)

Long-term treatment with clozapine and verbal memory performance in schizophrenia
por: Czepielewski, Letícia S., et al.
Publicado: (2018)

Medications Used for Cognitive Enhancement in Patients With Schizophrenia, Bipolar Disorder, Alzheimer’s Disease, and Parkinson’s Disease
por: Hsu, Wen-Yu, et al.
Publicado: (2018)

Cystine/Glutamate Antiporter in Schizophrenia: From Molecular Mechanism to Novel Biomarker and Treatment
por: Hung, Chung-Chieh, et al.
Publicado: (2021)

An Ensemble Approach to Predict Schizophrenia Using Protein Data in the N-methyl-D-Aspartate Receptor (NMDAR) and Tryptophan Catabolic Pathways
por: Lin, Eugene, et al.
Publicado: (2020)

Applying a bagging ensemble machine learning approach to predict functional outcome of schizophrenia with clinical symptoms and cognitive functions
por: Lin, Eugene, et al.
Publicado: (2021)

d-Amino Acids and pLG72 in Alzheimer’s Disease and Schizophrenia
por: Cheng, Yu-Jung, et al.
Publicado: (2021)

USE OF CLOZAPINE IN CHILDHOOD SCHIZOPHRENIA
por: Srinivasan, T.N., et al.
Publicado: (1997)

PM405. Sodium Benzoate Add-on Treatment for Refractory Schizophrenia: A Randomized, Double-Blind, Placebo-Controlled Trial
por: Lin, Chieh-Hsin, et al.
Publicado: (2016)

Long-Term Changes in Self-Report Auditory Verbal Hallucinations in Patients with Schizophrenia Using Clozapine
por: Chung, In Won, et al.
Publicado: (2019)

Polymorphism in the LASP1 gene promoter region alters cognitive functions of patients with schizophrenia
por: Lin, Chieh-Hsin, et al.
Publicado: (2019)

PICK1 Genetic Variation and Cognitive Function in Patients with Schizophrenia
por: Chen, Yi-Ting, et al.
Publicado: (2017)

C-reactive protein is associated with severity of thought and language dysfunction in patients with schizophrenia
por: Chang, Chun-Hung, et al.
Publicado: (2019)

PM420. Additional clinical effects of long-term clozapine therapy for chronic schizophrenia
por: Seo, Young Eun, et al.
Publicado: (2016)

Disability and quality of life in patients with treatment-resistant schizophrenia on long- term clozapine therapy
por: Nandakumar, Dhandapani, et al.
Publicado: (2023)

Genetic Effects of DISC1 and G72 (DAOA) on Visual Learning of Patients with Schizophrenia
por: Chang, Jane Pei-Chen, et al.
Publicado: (2020)

Severity in sustained attention impairment and clozapine-resistant schizophrenia: a retrospective study
por: Lin, An-Sheng, et al.
Publicado: (2019)

Combination of G72 Genetic Variation and G72 Protein Level to Detect Schizophrenia: Machine Learning Approaches
por: Lin, Eugene, et al.
Publicado: (2018)

Oxytocin in Schizophrenia: Pathophysiology and Implications for Future Treatment
por: Goh, Kah Kheng, et al.
Publicado: (2021)

Difference between treatment-resistant schizophrenia and clozapine-resistant schizophrenia
por: Tseng, Ping-Tao, et al.
Publicado: (2022)

The Relationships Between Hyperprolactinemia, Metabolic Disturbance, and Sexual Dysfunction in Patients With Schizophrenia Under Olanzapine Treatment
por: Wu, Tzu-Hua, et al.
Publicado: (2021)

Bone Density in Chronic Schizophrenia with Long-Term Antipsychotic Treatment: Preliminary Study
por: Lee, Tae-Young, et al.
Publicado: (2010)

Differential Impacts of Endogenous Antioxidants on Clinical Symptoms and Cognitive Function in Acute and Chronic Schizophrenia Patients
por: Lin, Chieh-Hsin, et al.
Publicado: (2023)

S41. SHORT- AND LONG-TERM OUTCOMES OF VITAMIN D SUPPLEMENTATION IN CLOZAPINE TREATED CHRONIC SCHIZOPHRENIA PATIENTS
por: Krivoy, Amir, et al.
Publicado: (2018)

Schizophrenia Patients Discharged on Clozapine Plus Long-Acting Injectable Antipsychotics From a Public Psychiatric Hospital in Taiwan, 2006–2021
por: Lin, Ta-Chun, et al.
Publicado: (2023)

Impact of clozapine monotherapy on gut microbiota and metabolism in people with schizophrenia
por: Yin, Feiyan, et al.
Publicado: (2023)

Effectiveness of clozapine in treatment-resistant schizophrenia
por: Raguraman, Janakiraman, et al.
Publicado: (2005)

Clozapine: Improvement of Negative Symptoms of Schizophrenia
por: Khan, Afaque H, et al.
Publicado: (2017)

Clozapine Response in Schizophrenia and Hematological Changes
por: Blackman, Graham, et al.
Publicado: (2021)

Clozapine discontinuation withdrawal symptoms in schizophrenia
por: Blackman, Graham, et al.
Publicado: (2021)

Management of patients with Clozapine Resistant Schizophrenia
por: Rajendran*, Nithya Ragavi, et al.
Publicado: (2022)

Treatment of Hypochondriasis in Two Schizophrenia Patients Using Clozapine
por: Tundo, Antonio, et al.
Publicado: (2017)

Does clozapine really affect bone mineral density? An experimental study
por: Aydin, Bahattin Kerem, et al.
Publicado: (2021)

Long-term outcomes of delayed clozapine initiation in treatment-resistant schizophrenia: a multicenter retrospective cohort study
por: Hatano, Masakazu, et al.
Publicado: (2023)

Brain Stimulation in Alzheimer's Disease
por: Chang, Chun-Hung, et al.
Publicado: (2018)

d-glutamate and Gut Microbiota in Alzheimer’s Disease
por: Chang, Chun-Hung, et al.
Publicado: (2020)

Machine Learning and Novel Biomarkers for the Diagnosis of Alzheimer’s Disease
por: Chang, Chun-Hung, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_8h8e4g7j16p9gtjr6o9hhkah2c